OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: BWIN 28.55%
Baldwin (BWIN) Q4 2025 Earnings Call Transcript
NASDAQ: AAOI 45.77%
Applied Optoelectronics (AAOI) Earnings Call
NASDAQ: PRAA 32.17%
PRA Group (PRAA) Q4 2025 Earnings Call Transcript
NASDAQ: BYND 32.83%
Expected US Company Earnings on Wednesday, February 25th, 2026
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: ACXIF 28.55%
NASDAQ: AAOI 28.55%
NASDAQ: PRAA 28.55%
NASDAQ: BYND 28.55%
